标题
Progressive tissue biomarker profiling in non-muscle-invasive bladder cancer
作者
关键词
-
出版物
Expert Review of Anticancer Therapy
Volume 18, Issue 7, Pages 695-703
出版商
Informa UK Limited
发表日期
2018-05-08
DOI
10.1080/14737140.2018.1474104
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
- (2017) Marko Babjuk et al. EUROPEAN UROLOGY
- Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review
- (2017) Viktor Soukup et al. EUROPEAN UROLOGY
- BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG
- (2017) Ashish M. Kamat et al. Nature Reviews Urology
- Characteristics and clinical significance of histological variants of bladder cancer
- (2017) Marco Moschini et al. Nature Reviews Urology
- Prognostic role of N-cadherin expression in patients with non–muscle-invasive bladder cancer
- (2017) Mohammad Abufaraj et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Tumor heterogeneity offibroblast growth factor receptor 3(FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment
- (2016) D. Pouessel et al. ANNALS OF ONCOLOGY
- Economic Burden of Bladder Cancer Across the European Union
- (2016) Jose Leal et al. EUROPEAN UROLOGY
- T1 high-grade bladder carcinoma outcome: the role of p16, topoisomerase-II α , survivin, and E-cadherin
- (2016) Maria Rosaria Raspollini et al. HUMAN PATHOLOGY
- The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder
- (2016) Romain Mathieu et al. Nature Reviews Urology
- The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non–muscle-invasive bladder cancer
- (2016) J. Alfred Witjes et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- p53 status correlates with the risk of progression in stage T1 bladder cancer: a meta-analysis
- (2016) Jun Du et al. World Journal of Surgical Oncology
- CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder
- (2015) Bo Wang et al. JOURNAL OF UROLOGY
- Expression profile of epithelial-mesenchymal transition markers in non–muscle-invasive urothelial carcinoma of the bladder: Correlation with intravesical recurrence following transurethral resection
- (2015) Bing Liu et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Correlation of tumor-infiltrating lymphocytes with bladder cancer recurrence in patients with solitary low-grade urothelial carcinoma
- (2015) Kristian Krpina et al. VIRCHOWS ARCHIV
- The prognostic value of P-cadherin in non-muscle-invasive bladder cancer
- (2014) P. Wang et al. EJSO
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder
- (2014) Lily C. Wang et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Prospective evaluation of a preoperative biomarker panel for prediction of upstaging at radical cystectomy
- (2013) Shahrokh F. Shariat et al. BJU INTERNATIONAL
- Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder
- (2013) E Xylinas et al. BRITISH JOURNAL OF CANCER
- Combination of molecular alterations and smoking intensity predicts bladder cancer outcome
- (2013) Anirban P. Mitra et al. CANCER
- Effect of Smoking on Outcomes of Urothelial Carcinoma: A Systematic Review of the Literature
- (2013) Joseph J. Crivelli et al. EUROPEAN UROLOGY
- Ki-67 is an independent indicator in non–muscle invasive bladder cancer (NMIBC); Combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC
- (2013) Weihong Ding et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Lower cyclooxygenase-2 expression is associated with recurrence of solitary non-muscle invasive bladder carcinoma
- (2012) Tomislav Tadin et al. Diagnostic Pathology
- ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers
- (2012) Ashish M. Kamat et al. EUROPEAN UROLOGY
- High Levels of Phosphatase and Tensin Homolog Expression Are Associated With Tumor Progression, Tumor Recurrence, and Systemic Metastases in pT1 Urothelial Carcinoma of the Bladder: A Tissue Microarray Study of 156 Patients Treated by Transurethral Resection
- (2012) Alcides Chaux et al. UROLOGY
- Impact of gender on bladder cancer incidence, staging, and prognosis
- (2011) Harun Fajkovic et al. WORLD JOURNAL OF UROLOGY
- International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy
- (2010) Shahrokh F. Shariat et al. BJU INTERNATIONAL
- Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer
- (2010) Bas W.G. van Rhijn et al. EUROPEAN UROLOGY
- Clinical Outcomes of Primary Bladder Carcinoma In Situ in a Contemporary Series
- (2010) Daher C. Chade et al. JOURNAL OF UROLOGY
- Cadherin Switching and Bladder Cancer
- (2010) Richard T. Bryan et al. JOURNAL OF UROLOGY
- Clinical Outcome of Primary Versus Secondary Bladder Carcinoma In Situ
- (2010) Daher C. Chade et al. JOURNAL OF UROLOGY
- Statistical consideration for clinical biomarker research in bladder cancer
- (2010) Shahrokh F. Shariat et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resection
- (2010) Mototsugu Muramaki et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Prognostic Value of p53 and Ki-67 Expression in Intermediate-risk Patients With Nonmuscle-invasive Bladder Cancer Receiving Adjuvant Intravesical Mitomycin C Therapy
- (2010) Ho Kyung Seo et al. UROLOGY
- Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study
- (2009) S. F. Shariat et al. CLINICAL CANCER RESEARCH
- Prognostic Accuracy of Individual Uropathologists in Noninvasive Urinary Bladder Carcinoma: A Multicentre Study Comparing the 1973 and 2004 World Health Organisation Classifications
- (2009) Matthias May et al. EUROPEAN UROLOGY
- Multi-Institutional Validation of the Predictive Value of Ki-67 Labeling Index in Patients With Urinary Bladder Cancer
- (2009) V. Margulis et al. JNCI-Journal of the National Cancer Institute
- Predictive Value of Combined Immunohistochemical Markers in Patients With pT1 Urothelial Carcinoma at Radical Cystectomy
- (2009) Shahrokh F. Shariat et al. JOURNAL OF UROLOGY
- Combination of Multiple Molecular Markers Can Improve Prognostication in Patients With Locally Advanced and Lymph Node Positive Bladder Cancer
- (2009) Shahrokh F. Shariat et al. JOURNAL OF UROLOGY
- Decision Analysis for the Evaluation of Diagnostic Tests, Prediction Models, and Molecular Markers
- (2008) Andrew J Vickers AMERICAN STATISTICIAN
- Comparison of Nomograms With Other Methods for Predicting Outcomes in Prostate Cancer: A Critical Analysis of the Literature
- (2008) S. F. Shariat et al. CLINICAL CANCER RESEARCH
- Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials
- (2007) Jesus Fernandez-Gomez et al. EUROPEAN UROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started